Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Novel Nanocomposites Based on Bacterial Polyester/LDH-SDS Clay for Stem Cells Delivery in Modern Wound Healing Management

Vasile E., Radu IC., Galateanu B., Rapa M., Hudita A., Jianu D.

Laboratory Study on Chronic Wound, published in Materials (Basel) (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Materials (Basel) (2020)
Reported sample size
—
Source database
Europe PMC
PMID
33050441
PMCID
PMC7601887
DOI
10.3390/ma13204488
Citations
5

Abstract (original English)

Nanocomposite materials based on poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBHV) and modified mineral clay layered double hydroxides (LDH-SDS) were explored as novel nanostructured materials for potential tissue engineering applications. The mineral clay inorganic phase was modified with an anionic long-chain structure of carbon atoms, such as sodium dodecyl sulfate, in order to increase the compatibility between the two phases. The melt intercalation method used for nanocomposite fabrication ensures a good dispersion of the modified LDH-SDS within the polymer matrix without using a toxic solvent (chloroform). The nanocomposites were found to have an intercalated/exfoliated structure with an enhanced Young modulus and increased stiffness. This could allow them to be considered for autologous stem cells dressings in the view of efficient wound healing applications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research